Master's position at #UZH @uzh_evolution
https://compbiozurich.org/positions/2024-06-10-position-master/#more
A massive binf. #rstats #methodsmatter
Deepak Tanwar
- 142 Followers
- 232 Following
- 29 Posts
Looking for meeting recommendations at the intersection of #PlantScience & #Bioinformatics. Geographically limited to East Canada, East USA, and Europe.
Community call: Pls let us know of any RNAseq, IsoSeq, ONT, or CAGE data that was submitted to @[email protected] @[email protected] @[email protected] in the last year that should be included as supporting evidence for the #AthalianaV12 reannotation. We know of some but you may know more. Please RT. #hivemind
🐦🔗: https://twitter.com/tair_news/status/1618767326685577217
TAIR @[email protected] on Twitter
“Community call: Pls let us know of any RNAseq, IsoSeq, ONT, or CAGE data that was submitted to @NCBI @emblebi @DDBJapan in the last year that should be included as supporting evidence for the #AthalianaV12 reannotation. We know of some but you may know more. Please RT. #hivemind”
Good news! I recently got funding for 2 PhD positions to do research on transposable element evolution. If you are interested or know someone who might be, please contact me (best by email).
🐦🔗: https://twitter.com/thomaswicker314/status/1618915481578250240
We are looking for master’s level students in bioinformatics @uzh_evolution: https://compbiozurich.org/positions/2022-12-15-position-master/
URPP Evolution in ActionSave the date!
https://www.evolution.uzh.ch/en/conference.html
https://www.evolution.uzh.ch/en/conference.html
Postdoctoral trainees wanted! We have several positions open in computational biology. Spatial? Single cell? Learn with us. We grow people.
https://tinyurl.com/3du3jmpa
We need to benchmark the benchmarks .. https://twitter.com/CrowellHL/status/1597579271945715717
🐦🔗: https://twitter.com/markrobinsonca/status/1597584905130872832
Evangelia PetsalakiFirst post! New preprint from group! https://www.biorxiv.org/content/10.1101/2022.11.17.516953v1
We integrated public multi-omics datasets collected upon treatment with ED surrogate risk factors and used network propagation to define an ED network. We then devised a new in silico KO strategy to prioritise 17 potential candidates for targeting ED to be tested in vitro. We found 8 potential candidate drugs for repurposing with a positive effect in at least one of the phenotypes tested and one (Molidustat) with an effect on both.